Saratoga Investment Earnings Calls
| Release date | Jul 14, 2026 |
| EPS estimate | $0.540 |
| EPS actual | - |
| Revenue estimate | 31.379M |
| Revenue actual | - |
| Expected change | +/- 2.26% |
| Release date | May 05, 2026 |
| EPS estimate | $0.530 |
| EPS actual | $0.530 |
| Revenue estimate | 30.853M |
| Revenue actual | 31.123M |
| Revenue Surprise | 0.87% |
| Release date | Jan 07, 2026 |
| EPS estimate | $0.590 |
| EPS actual | $0.610 |
| EPS Surprise | 3.39% |
| Revenue estimate | 30.94M |
| Revenue actual | 31.646M |
| Revenue Surprise | 2.28% |
| Release date | Oct 07, 2025 |
| EPS estimate | $0.670 |
| EPS actual | $0.580 |
| EPS Surprise | -13.43% |
| Revenue estimate | 32.51M |
| Revenue actual | 32.626M |
| Revenue Surprise | 0.355% |
Last 4 Quarters for Saratoga Investment
Below you can see how SAR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 07, 2025 |
| Price on release | $23.35 |
| EPS estimate | $0.670 |
| EPS actual | $0.580 |
| EPS surprise | -13.43% |
| Date | Price |
|---|---|
| Oct 01, 2025 | $24.10 |
| Oct 02, 2025 | $24.49 |
| Oct 03, 2025 | $24.40 |
| Oct 06, 2025 | $24.41 |
| Oct 07, 2025 | $23.35 |
| Oct 08, 2025 | $22.25 |
| Oct 09, 2025 | $22.05 |
| Oct 10, 2025 | $21.59 |
| Oct 13, 2025 | $21.87 |
| 4 days before | -3.11% |
| 4 days after | -6.34% |
| On release day | -4.71% |
| Change in period | -9.25% |
| Release date | Jan 07, 2026 |
| Price on release | $22.59 |
| EPS estimate | $0.590 |
| EPS actual | $0.610 |
| EPS surprise | 3.39% |
| Date | Price |
|---|---|
| Dec 31, 2025 | $23.07 |
| Jan 02, 2026 | $23.17 |
| Jan 05, 2026 | $23.55 |
| Jan 06, 2026 | $23.19 |
| Jan 07, 2026 | $22.59 |
| Jan 08, 2026 | $22.94 |
| Jan 09, 2026 | $23.22 |
| Jan 12, 2026 | $23.12 |
| Jan 13, 2026 | $23.01 |
| 4 days before | -2.08% |
| 4 days after | 1.86% |
| On release day | 1.55% |
| Change in period | -0.260% |
| Release date | May 05, 2026 |
| Price on release | $23.22 |
| EPS estimate | $0.530 |
| EPS actual | $0.530 |
| Date | Price |
|---|---|
| Apr 29, 2026 | $22.67 |
| Apr 30, 2026 | $23.30 |
| May 01, 2026 | $23.53 |
| May 04, 2026 | $23.89 |
| May 05, 2026 | $23.22 |
| May 06, 2026 | $22.50 |
| May 07, 2026 | $22.34 |
| May 08, 2026 | $22.15 |
| May 11, 2026 | $21.83 |
| 4 days before | 2.43% |
| 4 days after | -5.99% |
| On release day | -3.10% |
| Change in period | -3.71% |
| Release date | Jul 14, 2026 |
| Price on release | - |
| EPS estimate | $0.540 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $21.92 |
| Jun 16, 2026 | $22.22 |
| Jun 17, 2026 | $22.03 |
| Jun 18, 2026 | $22.09 |
| Jun 22, 2026 | $22.10 |
Saratoga Investment Earnings Call Transcript Summary of Q1 2026
Saratoga Investment Corp. reported fiscal Q1 2026 results with mixed near-term earnings but strong balance sheet and portfolio quality. Key positives: NAV rose to $396.4M (up 7.8% YoY), NAV per share was $25.52 (adjusted higher if excluding a one‑time monthly dividend timing effect), 12‑month ROE improved to 9.3% (above the BDC industry average), and adjusted NII per share increased sequentially to $0.66. Management declared a quarterly dividend of $0.75 ($0.25/month) yielding ~11.8% based on the July 7 stock price. The company ended the quarter with significant liquidity—$224M cash, $136M undrawn SBA debentures and undrawn revolvers—for a total ~$430M capacity, which management says provides flexibility to deploy capital accretively or manage debt maturities. Portfolio credit quality remains high (only two restructured nonaccruals), 86.9% first‑lien exposure, core non‑CLO portfolio ~1.7% above cost, and total portfolio fair value ~2.1% below cost. Activity was impacted by a slow lower‑middle‑market M&A environment and higher prepayments/refinancings, producing lower AUM and lower year‑over‑year NII primarily from lower short‑term rates and repayments. Management’s strategic response is disciplined underwriting, ramping business development hires to grow proprietary deal flow, selective deployment (including selective BB/BBB CLO debt investments), and maintaining liquidity and optionality to navigate uncertain macro conditions.
Sign In
Buy SAR